These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36702735)

  • 41. Optimising transitions of care for acute kidney injury survivors: protocol for a mixed-methods study of nephrologist and primary care provider recommendations.
    May HP; Krauter AK; Finnie DM; McCoy RG; Kashani KB; Griffin JM; Barreto EF;
    BMJ Open; 2022 Jun; 12(6):e058613. PubMed ID: 35732395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Community Pharmacists' Perceptions of Care Following the Implementation of a Transitions-of-Care Program.
    Graham J; Tusing LD; Gregor CM; Wright EA
    J Pharm Pract; 2020 Oct; 33(5):586-591. PubMed ID: 30669931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial.
    Kirwin JL; Cunningham RJ; Sequist TD
    J Manag Care Pharm; 2010 Mar; 16(2):104-13. PubMed ID: 20178395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive Pharmacist-led Transitions-of-care Medication Management around Hospital Discharge Adds Modest Cost Relative to Usual Care: Time-and-Motion Cost Analysis.
    Nuckols TK; Berdahl CT; Henreid AJ; Schnipper JL; Rauf A; Ko EM; Nguyen AT; Co Z; Fanikos J; Kim JH; Leang DW; Matta L; Mulligan K; Ray A; Shane R; Wassef K; Pevnick JM
    Inquiry; 2023; 60():469580231218625. PubMed ID: 38146178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Financial Sustainability of an Oregon Rural Health, Primary Care, and Pharmacist-Run Comprehensive Medication Management Program Through Direct Medical Billing.
    Hoover ND; Turner RB; Sampson J; Pye T; Hotan T
    J Manag Care Spec Pharm; 2020 Jan; 26(1):30-34. PubMed ID: 31880232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Project EVADE: Evaluating the effects of a pharmacist-run transitions of care clinic on hospital readmissions.
    Brauner MS; Accursi ML; Cantillo SL; Baxter MV; Burant CJ
    J Am Pharm Assoc (2003); 2020; 60(3):503-508. PubMed ID: 31866388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Information transmission to the community pharmacist after a patient's discharge from the hospital: setting up of a written medication discharge form, prospective evaluation of its impact, and survey of the information needs of the pharmacists].
    Claeys C; Dufrasne M; De Vriese C; Nève J; Tulkens PM; Spinewine A
    J Pharm Belg; 2015 Mar; (1):42-54. PubMed ID: 26571796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Post-discharge care following acute kidney injury: quality improvement in primary care.
    Howard SJ; Elvey R; Ohrnberger J; Turner AJ; Anselmi L; Martindale AM; Blakeman T
    BMJ Open Qual; 2020 Dec; 9(4):. PubMed ID: 33328317
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nephrotoxin Exposure in the 3 Years following Hospital Discharge Predicts Development or Worsening of Chronic Kidney Disease among Acute Kidney Injury Survivors.
    Schreier DJ; Rule AD; Kashani KB; Mara KC; Kane-Gill SL; Lieske JC; Chamberlain AM; Barreto EF;
    Am J Nephrol; 2022; 53(4):273-281. PubMed ID: 35294951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of a pharmacist-facilitated hospital discharge program: a quasi-experimental study.
    Walker PC; Bernstein SJ; Jones JN; Piersma J; Kim HW; Regal RE; Kuhn L; Flanders SA
    Arch Intern Med; 2009 Nov; 169(21):2003-10. PubMed ID: 19933963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of Pharmacist-Driven Transitions of Care Interventions on Post-hospital Outcomes Among Patients With Coronary Artery Disease: A Systematic Review.
    Weeda E; Gilbert RE; Kolo SJ; Haney JS; Hazard LT; Taber DJ; Axon RN
    J Pharm Pract; 2023 Jun; 36(3):668-678. PubMed ID: 34962844
    [No Abstract]   [Full Text] [Related]  

  • 52. Implementing post-discharge care following acute kidney injury in England: a single-centre qualitative evaluation.
    Elvey R; Howard SJ; Martindale AM; Blakeman T
    BMJ Open; 2020 Aug; 10(8):e036077. PubMed ID: 32792434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of community pharmacist-performed post-discharge medication reviews in transitions of care.
    Tetuan CE; Guthrie KD; Stoner SC; May JR; Hartwig DM; Liu Y
    J Am Pharm Assoc (2003); 2018; 58(6):659-666. PubMed ID: 30056133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implementation of a pharmacist-led transitional pharmaceutical care programme: Process evaluation of Medication Actions to Reduce hospital admissions through a collaboration between Community and Hospital pharmacists (MARCH).
    En-Nasery-de Heer S; Uitvlugt EB; Bet PM; van den Bemt BJF; Alai A; van den Bemt PMLA; Swart EL; Karapinar-Çarkit F; Hugtenburg JG
    J Clin Pharm Ther; 2022 Jul; 47(7):1049-1069. PubMed ID: 35306683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Post-Discharge Mortality and Rehospitalization among Participants in a Comprehensive Acute Kidney Injury Rehabilitation Program.
    Singh G; Hu Y; Jacobs S; Brown J; George J; Bermudez M; Ho K; Green JA; Kirchner HL; Chang AR
    Kidney360; 2021 Sep; 2(9):1424-1433. PubMed ID: 35373103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study.
    El Hajj MS; Kaddoura R; Abu Yousef SEA; Orabi B; Awaisu A; AlYafei S; Shami R; Mahfoud ZR
    Int J Clin Pharm; 2023 Jun; 45(3):630-640. PubMed ID: 36795303
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of a pharmacist-driven transitions of care clinic for a multisite integrated delivery network.
    Parodi M; Feeley B; Sanchez M
    Am J Health Syst Pharm; 2022 May; 79(11):844-851. PubMed ID: 35084448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of ambulatory care pharmacist intervention on 30-day readmission rates in high-risk transitions-of-care patients.
    Sutt AR; Alm R; Olson JL
    J Am Pharm Assoc (2003); 2023; 63(6):1694-1699. PubMed ID: 37169256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. impact of a Pharmacy-Led Transitions of Care Program Within a Primary Care-Based Accountable Care Organization.
    Joseph T; Hale GM; Moreau C; Kourtakis SL; Wolowich WR
    Sr Care Pharm; 2021 Jun; 36(6):311-316. PubMed ID: 34016228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacist-led transitions of care between hospitals, primary care clinics, and community pharmacies.
    Cossette B; Ricard G; Poirier R; Gosselin S; Langlois MF; Imbeault P; Breton M; Couturier Y; Sirois C; Lessard-Beaudoin M; Rodrigue C; Teasdale J; Turcotte JP; Mallet L
    J Am Geriatr Soc; 2022 Mar; 70(3):766-776. PubMed ID: 34817853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.